The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
Items 501–600 of 681
Potential of Probiotics as an Adjunct for Patients with Major Depressive Disorder
Cang, W., Wu, J., Ding, R., Wang, W., Li, N., Shi, H., Shi, L. S., Lee, Y. K., & Wu, R. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101057 · Cited by 7
Cytokine-Induced Sickness Behavior and Depression
Chang, Q., Szegedi, S. S., O’Connor, J. C., Dantzer, R., & Kelley, K. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_9 · Cited by 7
Ren, S., Qin, P., Wang, G., & Yang, J. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/4062632 · Cited by 6
Hong, S., Kim, Y., Kwon, Y., & Cho, S. (2024) · Nutrients · doi:10.3390/nu16132049 · Cited by 4
Maxeiner, H. G., Rojewski, M., Tumani, H., Herzog, S., Fuchs, D., Schmitt, A., Schmitt, M. W., & Bechter, K. (2009) · Acta Neuropsychiatrica · doi:10.1017/s0924270800032737 · Cited by 4
Tomioka, H., Masuda, J., Takada, A., & Iwanami, A. (2020) · Food and Nutrition Sciences · doi:10.4236/fns.2020.113013 · Cited by 4
Neamati, A., Shirzad, S., Vafaee, F., & Ghazavi, H. (2020) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.301342 · Cited by 5
Fisher, T. A., Kolyvanova, S. S., Pushnikov, A. A., & Николаевна, Л. О. (2020) · Problems of Balneology Physiotherapy and Exercise Therapy · doi:10.17116/kurort20209706140 · Cited by 4
Réus, G. Z., Abelaira, H. M., Coutellier, L. D., Manosso, L. M., & Pavlovic, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_3 · Cited by 4
Gumusoglu, S. B., Kiel, M. D., Gugel, A., Schickling, B., Weaver, K. R., Lauffer, M., Sullivan, H. R., Coulter, K. J., Blaine, B., Kamal, M., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01749-3 · Cited by 5
[Anatomo-echocardiographic correlation of scimitar syndrome in adults].
Espinola-Zavaleta, N. G., Muñoz‐Castellanos, L., Játiva-Chávez, S., & Zamora-González, C. (2005) · PubMed · Cited by 4
Miura, H., Shirokawa, T., Ozaki, N., & Isobe, K. (2010) · Health · doi:10.4236/health.2010.23032 · Cited by 4
Esawy, M. M., Shabana, M. A., & Ali, E. F. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2803-5 · Cited by 4
Is there a Role for Immunological Mechanisms in Etiopathogenesis of Obsessive Compulsive Disorder?
Rao, N. P., Reddy, M. S. S., & Reddy, J. Y. C. (2013) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.112192 · Cited by 4
Memahami Gangguan Depresi MayorPreprint
Rosyanti, L., Hadi, I., & Wijayati, F. L. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/fj6gk · Cited by 5
Li, W., Xiao, R., Chen, X., Pu, J., Chen, J., Wang, H., Liu, L., Li, D., Zhang, Y., Li, W. Y., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70549 · Cited by 3
Wang, X., Xu, J., Zhang, Y., Xu, W., & Gao, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07398-8 · Cited by 3
Lindahl, J., Veibäck, G. S., Suneson, K., Blanking, W., Tjernberg, J., Ståhl, D., Wiman, Å., Ventorp, F., Erhardt, S., & Lindqvist, D. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101221 · Cited by 3
Blaylock, R. L. (2008) · Cited by 3
Clinical Trials of Anti-Inflammatory Treatments of Major Depression
Müller, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00028-3 · Cited by 3
Self-citationWpływ mikrobiomu jelitowego na mózg i psychikę
Żakowicz, J., Bramorska, A., Zarzycka, W., Kovbasiuk, A., Kuć, K., & Brzezicka, A. (2020) · Kosmos · doi:10.36921/kos.2020_2634 · Cited by 6
Ilyin, N. P., Galstyan, D. S., Zolotova, A. E., Golushko, N. I., Tolkunova, V. N., Saklakova, D. K., Martynov, D. D., Apukhtin, K. V., Stewart, A., de Abreu, M. S., et al. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115676 · Cited by 4
Watt, D. F. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch10 · Cited by 3
Cytokines and the Immune–Neuroendocrine Network
Correa, S. G., Sotomayor, C. E., & Rodriguez‐Galán, M. C. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70012-0 · Cited by 3
Biomarkers of Depression: Potential Diagnostic Tools
Perković, M. N., Erjavec, G. N., Štrac, D. Š., & Pivac, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_3 · Cited by 5
Deng, Z., Gao, W., Liu, X., Hu, J. X., Deng, P., & Chi, L. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_181_17 · Cited by 4
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Frøkjær, V. G., Haarman, B. C. M., Jacobs, G. E., & Booij, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_4 · Cited by 3
Ye, S.-H., Zhao, Y., Liu, Z., Luo, C.-P., Xiong, J., Zhan, J., Li, Y., Wei, B., Chen, C., & Yang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1354999 · Cited by 7
Investigation of Neopterin and Neurophysiological Measurements as Biomarkers of Anxiety and Stress
Cronje, R., Beukes, J., Masenge, A., Toit, P. D., & Bipath, P. (2024) · NeuroRegulation · doi:10.15540/nr.11.1.25 · Cited by 3
Soedjana, H., Hasibuan, L. Y., Riestiano, B. E., Andayani, S., Nurfitriani, A., Sundoro, A., Putri, A. C., & Prasetyo, A. T. (2024) · JPRAS Open · doi:10.1016/j.jpra.2024.04.005 · Cited by 4
Neuroprotection Versus Neurotoxicity
Biber, K. P. H., & Block, M. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_6 · Cited by 3
Fitzgerald, K. N. (2011) · PubMed · Cited by 3
Is DNA methylation responsible for immune system dysfunction in schizophrenia?
Khojasteh-Fard, M., Tabrizi, M. H., & Amoli, M. M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.034 · Cited by 4
Anti-Inflammatory and Immune-Modulatory Therapeutic Approaches in Major Depression
Müller, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802456-0.00004-2 · Cited by 4
Self-citationBreaking Away: The Role of Homeostatic Drive in Perpetuating Depression
Toole, J. T., Rice, M. A., Craddock, T. J. A., Nierenberg, B. P., Klimas, N. G., FLETCHER, M. A., Zysman, J., Morris, M., & Broderick, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7828-1_8 · Cited by 3
The Impact of Inflammation on Brain Function and Behavior in Rodent Models of Affective Disorders
Farzana, F., Renoir, T., & Hannan, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00005-2 · Cited by 5
Kynurenine pathway in bipolar disorder
Konstantinou, G., Papageorgiou, C., & Angelopoulos, E. (2019) · Psychiatriki · doi:10.22365/jpsych.2018.294.338 · Cited by 3
Elsayed, M., & Connor, C. J. (2018) · EMJ Dermatology · doi:10.33590/emjdermatol/10312460 · Cited by 4
Psychosomatic medicine: old resources and new technologies
Mazo, G. E., Незнанов, Н. Г., & Rukavishnikov, G. V. (2023) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202312304214 · Cited by 3
Song, H., Zhang, H., Qin, X., Liu, Y., Lai, Y., Yang, W., Zhang, L., Hu, W., Wang, X., Zeng, J., et al. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111473 · Cited by 2
Dalui, S., Pal, S., Goswami, A., Sinha, A., Karar, S., Saha, A., Modak, P., Sil, M., Ratnaparkhi, P., Goswami, A., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05434-y · Cited by 2
The Future of Mental Health Care Toward an Integrative Paradigm
Lake, J. (2012) · InTech eBooks · doi:10.5772/30534 · Cited by 2
Lai, C. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.10.004 · Cited by 2
Convolvulus pluricaulis usage and depression
Shah, P. D., & Gupta, G. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00001-5 · Cited by 2
A cross talk on the role of contemporary biomarkers in depression
Vyas, A., & Doshi, G. (2024) · Biomarkers · doi:10.1080/1354750x.2024.2308834 · Cited by 2
Research Progress of Tryptophan and Its Metabolites in the Microbial-Gut-Brain Axis
唐, 婕. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1461901 · Cited by 2
A computational account of joint SSRI and anti-inflammatory treatment
Reneaux, M., Mayberg, H. S., Friston, K. J., & Pinotsis, D. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1472732 · Cited by 6
Strategies to Identify Biomarkers for Depression
Páez-Pereda, M., & Panhuysen, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_13 · Cited by 3
Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder
MacKinnon, D. F. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch50 · Cited by 3
La psiconeuroinmunología: Nueva visión sobre la salud y la enfermedad
Italo Marsiglia, G. (2009) · Gaceta Médica de Caracas · doi:10.47307/gmc.v117i3.18241 · Cited by 9
Sequeira‐Cordero, A., & Trías, J. F. (2009) · Americanae (AECID Library) · Cited by 24
In Vivo Evaluation of the Antidepressant Activity of a Novel Polyherbal Formulation
Verma, R. K. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000194 · Cited by 2
Improvement of late life depression after therapeutic enoxaparin: two case reports
Graham, D., Wu, Q. X., Gilligan, I., Ismail, R., & Walker, M. (2018) · Australasian Psychiatry · doi:10.1177/1039856218797441 · Cited by 2
Major Depressive Disorder and Food Hypersensitivity: A Case Report
Aucoin, M., & Bhardwaj, S. (2019) · Neuropsychobiology · doi:10.1159/000502963 · Cited by 3
Chronische Schmerzen aus psychiatrischer Sicht: Neurobiologie und Therapie
Popovic, A., Kuhn, M., & Pezawas, L. (2013) · Manuelle Medizin · doi:10.1007/s00337-012-1006-4 · Cited by 2
Defining Depression: Endogenous Materialities, Exogenous Immaterialities
García-Martínez, J. (2021) · Debats: Revista de cultura, poder i societat · doi:10.28939/iam.debats-en.2021-2 · Cited by 2
Understanding the Neurobiology of Bipolar Depression
Chintoh, A. F., & Young, L. T. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_6 · Cited by 2
Immune System and Mind-Body Medicine – An Overview
Calvillo, L., & Parati, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_9-1 · Cited by 2
Neuroprotective and Behavioral Benefits of Exogenous Ketone Supplementation-Evoked Ketosis
Kovács, Z., D’Agostino, D. P., & Ari, C. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197501207.003.0034 · Cited by 2
Neurobiology and the genetics of suicide
Wasserman, D., Wasserman, J., Rujescu, D., & Sokolowski, M. (2021) · doi:10.1093/med/9780198834441.003.0023 · Cited by 2
Aarsland, T. I. M., Haavik, J., Ulvik, A., Ueland, P. M., Dols, A., & Keßler, U. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100578 · Cited by 2
Finding the pathology of major depression through effects on gene interaction networks
Gaiteri, C. (2011) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
ROLE OF KYNURENINE PATHWAY METABOLITES IN DEPRESSION-A REVIEW
Soni, P., Singh, L., Singh, P. K., & Kumar, S. (2020) · Journal of Applied Pharmaceutical Sciences and Research · doi:10.31069/japsr.v3i3.1 · Cited by 1
Main Biochemical Aspects of the Pathogenesis of Depression. Part II
Дубинина, Е. Е., Schedrina, L. V., & Mazo, G. E. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01198-9 · Cited by 2
von Knebel, K., Staab, J., Gregus, A., Remling, L., Wirths, O., Spitzer, C., Herrmann‐Lingen, C., Reichardt, H. M., & Meyer, T. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100968 · Cited by 1
From memory disorders to the development of depression: A system approach
Grigoryan, G. A. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105440 · Cited by 1
Deng, Y., Xie, F., Guan, Y., Wu, W., Han, S., Jiang, H., & Guan, M. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120807 · Cited by 1
When Dryness Extends to the Brain: Brain-Related Non-Sicca Manifestations of Sjögren’s Disease
Kolanko, M., Grabowska, J., & Sebastian, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103954 · Cited by 3
Chmielewski, G., Mikiewicz, M., Kuna, J., Jaśkiewicz, Ł., Czerwińśka, J., Majewski, M. S., & Krajewska–Włodarczyk, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167251 · Cited by 1
Understanding the neurobiology of bipolar depression
Wang, J.-F., & Young, L. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_6 · Cited by 1
Neuroimaging and Clinical Studies on Brain–Immune Interactions
Hannestad, J. O. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_4 · Cited by 1
Walker, A. K., Dantzer, R., & Kelley, K. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_6 · Cited by 2
Role of Regulatory Subsets During Aging
Wardowska, A., & Trzonkowski, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_18 · Cited by 1
Pineda, B., Campos‐Peña, V., Lugo-Huitrón, R., Ríos, C., & de la Cruz, V. P. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_13 · Cited by 1
Sidorova, Y. V., Obraztsova, O. G., Евдокимов, Д. В., Абрамец, И. И., & Talalayenko, A. N. (2013) · Neurophysiology · doi:10.1007/s11062-013-9357-6 · Cited by 1
Ducasse, D., Girod, C., & Courtet, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_10 · Cited by 2
The Role of Genetic and Environmental Risk Factors in Aetiology of Suicidal Behaviour
Zainullina, A., Valiullina, A., & Хуснутдинова, Э. К. (2016) · Palgrave Macmillan UK eBooks · doi:10.1057/9781137437327_11 · Cited by 3
Efeitos dos ácidos graxos Ômega-3 no tratamento do transtorno depressivo maior: uma revisão
Santos, R. N. C. (2016) · International Journal of Nutrology · doi:10.1055/s-0040-1705274 · Cited by 2
The neuroprogressive nature of bipolar disorder: Mechanisms and implications
Singhal, G., & Baune, B. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00003-x · Cited by 2
Wederkerige interacties tussen chronische stress en het neuro-endocriene en immuunsysteem
Moss, S. C., Drexhage, H. A., & Rutten, S. (2021) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2683-9_2 · Cited by 1
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7264-3_8 · Cited by 1
Self-citationMicronutrients and Depression: Is There Any Association?
Ong, K. K.-Y. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_6 · Cited by 1
Early-life stress exposure and epigenetic programming
Farrell, C. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821785-6.00001-3 · Cited by 1
Involvement of Glial Cells in the Pathophysiology and Treatment of Depression
Fatimi, H. E., & Khalki, L. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch017 · Cited by 1
Carbohydrate and protein metabolism
Nishimura, T., & Yoshinari, Y. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95424-2.00011-x · Cited by 1
The HPA axis and GABA-Glutamate Systems as Potential Antidepressant Targets in Prostate Cancer
Sharpley, C. F. (2011) · The Open Prostate Cancer Journal · doi:10.2174/1876822901104010001 · Cited by 1
Circulating Biomarkers of Inflammation, Adhesion, and Hemostasis in Behavioral Medicine
Mills, P. J., & von Känel, R. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_45 · Cited by 1
Role of Regulatory Subsets During Aging
Trzonkowski, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_18 · Cited by 1
Dornbierer, D. (2019) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-b-000348232 · Cited by 1
Short but Continuous Natural Pain for Depression Treatment and BeyondPreprint
Huang, M. (2018) · Preprints.org · doi:10.20944/preprints201805.0411.v1 · Cited by 1
Effect of Unrestricted Access to Running Wheels on Cancer-Related Fatigue
Little, C. (2011) · The Knowledge Bank (The Ohio State University)
Guan, S. A. (2015) · eScholarship (California Digital Library)
Wang, Y. (2014) · Digital Commons - East Tennessee State University (East Tennessee State University)
Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen
Müller, N., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_5 · Cited by 1
Self-citationJans, L. A. W. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20080530lj
Dysregulation of the kynurenine pathway in psychotic disorders : immunological aspects
Kegel, M. E. (2014) · Figshare
Relation of genes regulating the HPA-axis to major depression and suicidality: novel findings
Wasserman, D., Sokolowski, M., & Wasserman, J. (2015) · Suicidologi/Nytt i suicidologi · doi:10.5617/suicidologi.1787
Duloxetine-Modulating Effects of Brain Structure in Major Depressive Disorder With Panic Disorder
Lai, C. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ca4b8b
Antidepressants in counselling psychology: Relevance, effectiveness and implications for practice
Sharpley, C. F. (2011) · Counselling Psychology Quarterly · doi:10.1080/09515070.2011.589245 · Cited by 1
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.